Functional activity of blood polymorphonuclear leukocytes as an oxidative stress biomarker in human subjects

Free Radical Biology and Medicine

Volumn 24, Issue 9, 1998, Pages 1411-1418

  Chan, Sandra S ^a   Monteiro, Hugo P ^b   Deucher, Guilherme P ^a   Abud, Ronaldo L ^a   Abuchalla, Daud ^a   Junqueira, Virginia B C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FUNDAÇÃO PRÓ SANGUE HEMOCENTRO DE SÃO PAULO   (Brazil)

Author keywords

Aging; Antioxidants; Cardiovascular diseases; Chemiluminescence; Free radicals; Oxidative stress; Polymorphonuclear leukocytes; Reactive oxygen species

Indexed keywords

ADULT; AGED; AGING; ARTICLE; CARDIOVASCULAR DISEASE; CHEMOLUMINESCENCE; CHOLESTEROL BLOOD LEVEL; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; AGING; ANTIOXIDANTS; BIOLOGICAL MARKERS; CANDIDA ALBICANS; CHEMILUMINESCENT MEASUREMENTS; CHOLESTEROL; CHOLESTEROL, LDL; CORONARY DISEASE; FEMALE; FERRITINS; HUMANS; LIPOPROTEINS; LUMINOL; MALE; MIDDLE AGED; NEUTROPHILS; OXIDATIVE STRESS; PHAGOCYTOSIS;

EID: 0031864193     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(98)00010-0     Document Type: Article

References (63)

1. Kehrer J. P. Free radicals as mediators of tissue injury and disease. Crit. Rev. Toxicol. 23:1993;21-48.
2. Sies H. Oxidative stress. 1991;Academic Press, San Diego.
3. Babior B. M., Kipnes R. S., Curnutte J. T. The production by leukocytes of superoxide; A potential bactericidal agent. J. Clin. Invest. 52:1973;741-744.
4. Zucker-Franklin D., Hirsch J. G. Electron microscope studies on the degranulation of rabbit peritoneal leukocytes during phagocytosis. J. Exp. Med. 120:1964;569-576.
5. Babior B. M. Oxygen-dependent microbial killing by phagocytes. N. Engl. J. Med. 298:1978;659-668.
6. Malech H. L., Gallin J. I. Neutrophils in human diseases. N. Engl. J. Med. 317:1987;687-694.
7. Abdalla D. S. P., Campa A., Monteiro H. P. Low density lipoprotein oxidation by stimulated neutrophils and ferritin. Atherosclerosis. 97:1992;149-159.
8. Assmann G., Schulte H. Role of triglycerides in coronary artery disease Lessons from the prospective cardiovascular münster study . Am. J. Cardiol. 70:1992;10H-13H.
9. Ludwig P. W., Hunninghake D. B., Hoidal J. R. Increased leukocyte oxidative metabolism in hyperlipoproteinaemia. Lancet. 14:1982;348-350.
10. Araújo F. B., Barbosa D. S., Hsin C. Y., Maranhão R. C., Abdalla D. S. P. Evaluation of oxidative stress in patients with hyperlipidemia. Atherosclerosis. 117:1995;61-71.
11. Fu Y., Arkins S., Li Y. M., Dantzer R., Kelley K. W. Reduction in superoxide anion secretion and bactericidal activity of neutrophils from aged rats Reversal by combination gamma interferon and growth hormone . Infect. Immun. 62:1994;1-8.
12. Fülöp T. Jr, Fóris G., Wórum I., Leövey A. Age-dependent alterations of Fc γ-receptor-mediated effector functions of human polymorphonuclear leukocytes. Clin. Exp. Immunol. 61:1985;425-432.
13. Nagel J. E., Pyle R. S., Chrest F. J., Adler W. H. Oxidative metabolism and bactericidal capacity of polymorphonuclear leukocytes from normal young and aged adults. J. Gerontol. 37:1982;529-534.
14. McCafferty A. C., Cree I. A., McMurdo M. E. T. The influence of age and sex on phagocyte chemiluminescence. J. Biolumin. Chemilumin. 10:1995;41-48.
15. Fülöp T. Jr, Varga Z., Nagy J. T., Fóris G. Studies on opsonized zymosan, FMLP, carbachol, PMA and A23187 stimulated respiratory burst of human PMNLs. Biochem. Int. 17:1988;419-426.
16. Mello S. B. V., Farsky S. H. P., Sannomiya P., Garcia-Leme J. Inhibition of neutrophil chemotaxis and chemokinesis associated with a plasma protein in aging rats Selective depression of cell responses mediated by complement-derived chemoattractants . J. Leukoc. Biol. 51:1992;46-52.
17. Deucher G. P. Antioxidant therapy in the aging process. Emerit I., Chance B. Free radicals and aging. 1991;428-437 Birkhäuser Verlag, Basel, Switzerland.
18. Zeligs B. J. Bactericidal and fungicidal assay. Herscowitz H. B., Holden H. T., Bellanti J. A., Ghaffar A. Manual of macrophage methodology Collecttion, characterization and function . 1981;123-129 Marcel Dekker, New York.
19. Rosenfeld G. Método rápido de coloração de esfregaços de sangue. Noç es práticas sobre corantes pancrômicos e estudo de diversos fatores. Mem. Inst. Butantan. 20:1947;315-328.
20. Kaplan L. A., Pesce A. J., Kazmierczak S. C. Clinical chemistry, theory, analysis and correlation. St. 1996;699 Mosby-Year Book, Inc. Louis, MO.
21. Assman G., Schulte H. Role of triglycerides in coronary artery disease Lessons from the prospective cardiovascular münster study . Am. J. Cardiol. 70:1992;10H-13H.
22. Gotto A. M. Hypertriglyceridemia Risks and perspectives . Am. J. Cardiol. 70:1992;19H-22H.
23. Quinn M. T., Parthasarathy S., Fong L. G., Steinberg D. Oxidatively modified low density lipoproteins A potential role in recruitment and retention of monocyte/macrophages during atherogenesis . Proc. Natl. Acad. Sci. USA. 84:1987;2995-2998.
24. Steinberg D. Metabolism of lipoproteins and their role in the pathogenesis of atherosclerosis. Atheroscler. Rev. 18:1988;1-12.
25. Steinberg D., Parthasarathy S., Carew T. E., Khoo J. C., Witztum J. L. Beyond cholesterol. Modifications of low density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320:1989;915-927.
26. Parthasarathy S., Rankin S. H. Role of oxidized low density lipoprotein in ahterogenesis. Prog. Lipid Res. 31:1992;127-135.
27. Henriksen, T.; Mahoney, E. M.; Steinberg, D. Arteriosclerosis 3:149-159; 1983.
28. Hessler J. R., Morel D. W., Leewis L. J., Chisolm G. M. Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis. 3:1983;215-228.
29. Cathcart M. K., Morel D. W., Chisolm G. M. Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic. J. Leukoc. Biol. 38:1985;341-352.
30. Hermann W. J., Ward K., Faucett J. The effect of tocopherol on high density lipoprotein cholesterol. Am. J. Clin. Pathol. 72:1979;848-852.
31. Muckle T. J., Nazir D. J. Variation in human blood high-density lipoprotein response to oral vitamin E megadosage. Am. J. Clin. Pathol. 91:1989;165-171.
32. Hatan L. J., Kayden H. J. The failure of α-tocopherol supplementation to alter the distribution of lipoprotein cholesterol in normal and hyperlipoproteinemic persons. Am. J. Clin. Pathol. 76:1981;122-124.
33. Kesaniemi Y. A., Grundy S. M. Lack of effect of tocopherol on plasma lipids and lipoproteins in man. Am. J. Clin. Nutr. 36:1982;224-228.
34. Singh R. B., Rastogy S. S., Ghosh S., Niaz M. A., Singh N. K. The diet and moderate exercise trial (DAMET) Results after 24 weeks . Acta Cardiol. 158:1993;543-557.
35. Clevidence B. A., Lehmann J. Alpha-and-gamma-tocopherol levels in lipoproteins fractionated by affinity chromatography. Lipids. 24:1989;137-140.
36. Janero D. R. Therapeutic potential of vitamin E in pathogenesis of spontaneous atherosclerosis. Free Radic. Biol. Med. 11:1991;129-144.
37. Chupukcahroen N., Komaratat P., Wilairat P. Effects of vitamin E deficiency on the distribution of cholesterol in plasma lipoproteins and the activity of cholesterol 7 β-hydroxilase in rabbit liver. J. Nutr. 115:1985;468-472.
38. Salonen J. T., Nyyssönen K., Korpela H., Tuomelehto J., Seppänen R., Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation. 86:1992;803-811.
39. Halliwell B, Gutteridge J. M. C. Free radicals in biology and medicine. 2nd ed. 1989;Clarendon Press, Oxford.
40. Niwa Y., Kasama T., Miyachi Y., Kanoh T. Neutrophils chemotaxis, phagocytosis and parameters of reactive oxygen species in human aging Cross-sectional and longitudinal studies . Life Sci. 44:1989;1655-1664.
41. Kumar V., Contran R. S., Robbins S. L. Basic pathology. 1992;W. B. Sanders Co. Philadelphia.
42. Fantone J. C., Ward P. A. Inflammation. Rubin F. E. Pathology. 1994;33-66 J. B. Lippincott, Philadelphia.
43. Suzuki K., Swenson C., Sasagawa S., Sakatani T., Watanabe M., Kobayashi M., Fujikura T. Age-related decline in lysossomal enzyme release from polymorphomuclear leukocytes after N-formyl-methionyl-leucyl-phenylalanine stimulation. Exp. Hematol. 11:1983;1005-1013.
44. McLaughlin B., O'Malley K., Cotter T. G. Age-related differences in granulocyte chemotaxis and degranulation. Clin. Sci. 70:1986;59-62.
45. Weismann G., Dukor P., Zurier R. B. Effect of cyclic AMP on release of lysossomal enzymes from phagocytes. Nature. 231:1971;131-138.
46. Choi J., Yu B. P. Brain synaptosomal aging Free radicals and membrane fluidity . Free Radic. Biol. Med. 18:1995;133-139.
47. Masuda M., Komiyama Y., Murakami T., Murata K., Hasui M., Hirabayashi Y., Kobayashi Y. Difference in changes of membrane fluidity of polymorphonuclear leukocytes stimulated with phorbol myristate acetate and formyl-metionyl-leucyl-phenylalanine - Role of excited oxygen species. J. Leukoc. Biol. 47:1990;105-110.
48. Harman D. Aging A theory based on free radical and radiation chemistry . J. Gerontol. 11:1956;298-301.
49. Fülop T., Jr; Varga Z., Csongor J., Fóris G., Leövey A. Age related impairment in phosphatidylinositol breakdown of polymorphonuclear granulocytes. FEBS Lett. 2245:1989;249-252.
50. Lipschitz D. A., Udupa K. B., Boxer L. A. The role of calcium in the age-related decline of neutrophil function. Blood. 71:1988;659-665.
51. Varga Z., Kovács E. M., Paragh G., Jacob M., Robert L., Fülop T. Jr. Effect of elastin peptides and N-formyl-methionyl-leucyl-phenylanine on cytosolic free calcium in polymorphonuclear leukocytes of healthy middle-aged and elderly subjects. Clin. Biochem. 21:1988;127-130.
52. Mohácsi A., Fülop T. Jr, Kozlovszky B., Seres I., Leövey A. Superoxide anion production and intracellular free calcium levels in resting and stimulated polymorphonuclear leukocytes obtained from healthy and arteriosclerotic subjects of various ages. Clin. Biochem. 25:1992;285-288.
53. Korchak H. M., Vienne K., Rutherford L. E., Wilkenfeld C., Finkelstein M. C., Weissmann G. Stimulus response coupling in the human neutrophil. II. Temporal analysis of changes in cytosolic calcium and calcium effux. J. Biol. Chem. 259:1984;4076-4082.
54. Boxer L. A. Regulation of phagocyte function by α-tocopherol. Proc. Nutr. Soc. 45:1986;333-344.
55. Dahlgren F. R., Stendhal O. Role of myeloperoxidase in luminol-dependent chemiluminescence of polymorphonuclear leukocytes. Infect. Immun. 39:1983;731-741.
56. Kettle A. J., Winterbourn C. C. Superoxide enhances hypoclorous acid production by stimulates human neutrophils. Biochim. Biophys. Acta. 1052:1990;379-385.
57. Yagi K. Assay for serum lipid peroxide level and its clinical significance. Yagi K. Lipids peroxides in biology and medicine. 1982;223-243 Academic Press Inc. Orlando, FL.
58. 2 protection of membranes from lipid peroxidation damage. Trends Biol. Sci. 12:1987;31-34.
59. Cooper R. A. Abnormalities of cell-membrane fluidity in the pathogenesis of disease. N. Engl. J. Med. 297:1977;371-377.
60. McMurche E. J., Ranson J. K. Membrane lipid fluidity and its effect on the ativation energy of membrane-associated enzymes. Biochim. Biophys. Acta. 554:1979;364-374.
61. Maeba R., Maruyama A., Tarutani O., Ueta N., Shimasaki H. Oxidized low-density lipoprotein induces the production of superoxide by neutrophils. FEBS Lett. 377:1995;309-312.
62. Fries D. M., Penha R. G., D'Amico E. A., Abdalla D. S. P., Monteiro H. P. Oxidized low-density lipoprotein stimulates nitric oxide release by rabbit aortic endothelial cells. Biochem. Biophys. Res. Commun. 207:1995;231-237.
63. Salvayre A. N., Fitoussi G., Réaud V., Pieraggi M. T., Thiers J. C., Salvayre R. A delayed and sustained rise of cytosolic calcium is elicited by oxidized LDL in culturred bovine aortic endothelial cells. FEBS Lett. 299:1992;60-65.